je.st
news
Endo to pay $25M for nasal testosterone replacement therapy
2014-11-25 00:20:24| Biotech - Topix.net
Endo International made a bigger push into the testosterone replacement therapy market Monday by agreeing to acquire the rights to Natesto for $25 million. Natesto is the only testosterone nasal gel approved by the Food and Drug Administration as a replacement therapy for adult males with hypogonadism - a condition where sex glands produce little or no sex hormones.
Tags: pay
therapy
replacement
25m
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|